Orbimed Advisors - OLEMA PHARMACEUTICALS INC ownership

OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of OLEMA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$22,263,000
-1.5%
807,7920.0%0.24%
+7.0%
Q2 2021$22,602,000
+3.8%
807,792
+23.1%
0.23%
+12.3%
Q1 2021$21,770,000
-30.4%
656,126
+0.8%
0.20%
-25.5%
Q4 2020$31,300,000650,9920.27%
Other shareholders
OLEMA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Paradigm Biocapital Advisors LP 7,803,600$96,374,4606.54%
Logos Global Management LP 3,743,875$46,236,8566.17%
MPM BioImpact LLC 1,857,681$22,942,3606.12%
Cormorant Asset Management, LP 4,504,764$55,633,8353.24%
BVF INC/IL 9,135,893$112,828,2793.04%
Vivo Capital, LLC 1,873,704$23,140,2442.54%
Altium Capital Management LP 335,000$4,137,2502.16%
SILVERARC CAPITAL MANAGEMENT, LLC 407,801$5,036,3421.53%
HighVista Strategies LLC 247,880$3,061,3181.42%
ACUTA CAPITAL PARTNERS, LLC 153,007$1,889,6361.27%
View complete list of OLEMA PHARMACEUTICALS INC shareholders